Choi Young-ho, CEO
WELLS BIO uplifts patient care with innovative diagnostic technologies
- Its recent product, the G6PD Biosensor, is the world’s first glucose-6-phosphate dehydrogenase quantitative test delivering results in four minutes
Supported by:
Discovery Reports
Choi Young-ho, CEO